Perbak Capital Partners »

Vaxcyte shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 41k 36.02
2025-06-30 $859k 26k 32.51

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr Indl (XLI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust S&p Ins Etf (KIE)
Select Sector Spdr Tr Technology (XLK)
Elanco Animal Health (ELAN)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Financial (XLF)
Ubs Group SHS (UBS)
Qiagen Nv Com Shs (QGEN)
D.R. Horton (DHI)
Mettler-Toledo International (MTD)

View all positions for Perbak Capital Partners

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
BlackRock
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Westfield Capital Management Company
Kynam Capital Management
Deep Track Capital
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Vaxcyte